MDKA:IDXPT Merdeka Copper Gold Tbk Analysis
Data as of 2026-08-26 - not real-time
IDR 3,120.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
At IDR 3,120.00, PT Merdeka Copper Gold Tbk shows no decisive moving-average alignment, leaving the trend neutral. Over a rolling month the price has gained 18.2%. With RSI at 65.9 the momentum picture is approaching overbought, alongside a bullish MACD signal. The recent range runs from support at IDR 2,550.00 up to resistance at IDR 3,180.00.
Valuation screens as overvalued, on a P/E of 1752.8 with no clean sector comparison available. Analyst price targets sit 24.9% above the current price. Revenue is growing at 23.5% on a -0.0% profit margin. The 0.42% dividend yield looks stretched against payout coverage.
The composite risk read is 7/10, putting it in elevated territory. With 30-day volatility of 41.2%, a beta of 0.90 and a maximum drawdown of 44.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 3 out of 10.
Valuation screens as overvalued, on a P/E of 1752.8 with no clean sector comparison available. Analyst price targets sit 24.9% above the current price. Revenue is growing at 23.5% on a -0.0% profit margin. The 0.42% dividend yield looks stretched against payout coverage.
The composite risk read is 7/10, putting it in elevated territory. With 30-day volatility of 41.2%, a beta of 0.90 and a maximum drawdown of 44.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 3 out of 10.
Top Market Events
HONG KONG, June 26, 2026 - ACN Newswire - PT Merdeka Gold Resources Tbk 'Merdeka Gold Resources', 'MGR' or the...Merdeka Gold Keeps Pani Gold Mine Expansion on Track as Heap Leach Ramps Up and 12 Mtpa Carbon-in-Leach Project Advances
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading above the 200-day average of 2831.70
- MACD momentum is positive
- 30-day price change of +18.2%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Dividend yield of 0.42% looks stretched against payout coverage
- Trading above the 200-day average of 2831.70
- Analyst targets imply +24.9% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- Dividend yield of 0.42% looks stretched against payout coverage
- Negative profit margin of -0.0%
- Analyst targets imply +24.9% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth23.50%
Profit Margin-0.04%
P/E Ratio1752.8
ROE4.48%
ROA3.32%
Debt/Equity76.50
P/B Ratio89142.9
Op. Cash FlowIDR365.5M
Free Cash FlowIDR-348990432
Technical Analysis
TrendNeutral
RSI65.9
SupportIDR 2,550.00
ResistanceIDR 3,180.00
MA 20IDR 2,861.50
MA 50IDR 2,760.20
MA 200IDR 2,831.70
MACDBullish
VolumeStable
Fear & Greed Index93.84
Valuation
Fair ValueIDR 0.27
Target PriceIDR 3,896.26
Upside/Downside24.88%
GradeOvervalued
TypeGrowth
Dividend Yield0.42%
Risk Assessment
Beta0.90
Volatility41.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.